Literature DB >> 4268240

Cytotoxic drugs in treatment of nonmalignant diseases.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4268240     DOI： 10.7326/0003-4819-76-4-619

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  Cytoxan and future sterility.

Authors:  C F Piel
Journal:  West J Med       Date:  1976-01

2.  Treatment of Behcet's disease with chlorambucil.

Authors:  D Tricoulis
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

Review 3.  Problems with immunosuppressive agents in renal disease.

Authors:  J S Cameron
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

4.  The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.

Authors:  J A Baltus; J W Boersma; A P Hartman; J P Vandenbroucke
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

5.  Immunosuppressive therapy of ocular disease.

Authors:  W B Boone; L Slater
Journal:  J Natl Med Assoc       Date:  1979-09       Impact factor: 1.798

6.  Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

Review 7.  Remission-inducing drugs in rheumatoid arthritis.

Authors:  T P Anastassiades
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

8.  Intermittent cyclophosphamide in pemphigus vulgaris and bullous pemphigoid.

Authors:  A Medved; I Maxwell
Journal:  Can Med Assoc J       Date:  1974-08-03       Impact factor: 8.262

9.  Intermittent cyclophosphamide treatment of autoimmune thombocytopenia.

Authors:  B Weinerman; I Maxwell; W Hryniuk
Journal:  Can Med Assoc J       Date:  1974-11-16       Impact factor: 8.262
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.